Health-related quality-of-life assessment in patients with cutaneous T-cell lymphoma.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Archives of Dermatology

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHPEDI.161.4.356PMID 15781673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase 1/2 pilot study of methotrexate-laurocapram topical gel for the treatment of patients with early-stage mycosis fungoides.

  2003cited by this paper
• Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma.

  2003cited by this paper
• Quality of Life Assessment in Nonmelanoma Cervicofacial Skin Cancer

  2003influential reference
• The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review.

  2002cited by this paper
• Vaccination therapy for cutaneous T‐cell lymphoma

  2002cited by this paper
• Quantifying the harmful effect of psoriasis on health-related quality of life.

  2002influential reference
• Advances in quality of life measurements in oncology patients.

  2002cited by this paper
• Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphoma.

  2002cited by this paper
• Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire.

  2002cited by this paper
• Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

  2001cited by this paper
• Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma.

  2001cited by this paper
• The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.

  2001influential reference
• Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results.

  2001cited by this paper
• Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.

  2000cited by this paper
• The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms.

  2000cited by this paper
• Primary cutaneous lymphomas

  2000cited by this paper
• Understanding Research about Quality of Life and other Health Outcomes

  1999cited by this paper
• Measuring health-related quality of life.

  1999cited by this paper
• Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument

  1999cited by this paper
• Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.

  1999cited by this paper
• Acne vulgaris and the quality of life of adult dermatology patients.

  1998cited by this paper
• Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases.

  1997cited by this paper
• Quality of life measurement in dermatology: a practical guide

  1997cited by this paper
• Quality of care in dermatology. The state of (measuring) the art.

  1997influential reference
• Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease.

  1997cited by this paper
• Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

  1997cited by this paper
• Quality-of-life end points in cancer clinical trials: the U.S. Food and Drug Administration perspective.

  1996cited by this paper
• Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system

  1996cited by this paper
• Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

  1996cited by this paper
• Assessment of quality-of-life outcomes.

  1996cited by this paper
• Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study.

  1995cited by this paper
• The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.

  1994cited by this paper
• Criterion validity and reliability of the SF-36 in a population sample

  1994cited by this paper
• The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups

  1994cited by this paper
• A critical appraisal of the quality of quality-of-life measurements.

  1994cited by this paper
• The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs

  1993cited by this paper
• The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

  1993cited by this paper
• Measuring Health-Related Quality of Life

  1993cited by this paper
• The MOS 36-Item Short-Form Health Survey (SF-36)

  1992cited by this paper
• The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection

  1992cited by this paper
• Validating the SF-36 health survey questionnaire: new outcome measure for primary care.

  1992cited by this paper
• Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

  1981cited by this paper

• Protocol for a mixed-methods modified Delphi study for the development of a core domain set to assess the health-related quality of life of patients with mycosis fungoides and Sézary syndrome in clinical trials

  2026cites this paper
• Defining Core Concepts for Health‐Related Quality of Life for Patients With Mycosis Fungoides and Sézary Syndrome: A Systematic Literature Review

  2025cites this paper
• Strahlentherapie bei kutanen Lymphomen: Empfehlungen der EORTC-Arbeitsgruppe für kutane Lymphome

  2025cites this paper
• Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group

  2025cites this paper
• Assessing Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome: Unmet Needs

  2024cites this paper
• Evaluation of Quality of Life and Treatment Satisfaction in Newly Diagnosed Cutaneous T-Cell Lymphoma Patients

  2024influential citation
• Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients

  2024cites this paper
• Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group.

  2024cites this paper
• Health‐related quality of life in cutaneous T‐cell lymphoma: A post hoc analysis of a phase 3 trial in mycosis fungoides and Sézary syndrome

  2024cites this paper
• Biochemical and hormonal abnormalities in adult female acne

  2023cites this paper
• Significance of insulin and insulin-like growth factor-1 in the pathogenesis of acne

  2023cites this paper
• Adult female acne: relevance and possible solutions

  2023cites this paper
• Lebensqualität von Patienten mit Mycosis fungoides und Sézary-Syndrom

  2023cites this paper
• Dermatoses in overweight and obese children and their relationship with insulin and skin color

  2023cites this paper
• Correlation between the plasma levels of TNF-α, IL-1α, AND IL-8 and acne vulgaris severity

  2023cites this paper
• Metabolic and Dietary Factors in Acne Vulgaris and Evaluation of the Acne Vulgaris Treatment with Oral Contraceptive-Based Therapies in Young Adult Women

  2023cites this paper
• Unveiling the hidden struggles: Exploring the profound impact of advanced stage cutaneous T‐cell lymphoma on quality of life

  2023cites this paper
• Evaluation of Serum Interleukin 36 in Pityriasis rosea Patients

  2022cites this paper
• Fatty Acid Profiling in Facial Sebum and Erythrocytes From Adult Patients With Moderate Acne

  2022cites this paper
• Cognition/Psychological Burden and Resilience in Cutaneous T-Cell Lymphoma and Psoriasis Patients: Real-Life Data and Implications for the Treatment

  2022cites this paper
• Association of Acne Tarda with Endocrinological Disorders

  2022cites this paper
• Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations

  2022cites this paper
• Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator

  2022cites this paper
• EORTC‐QLQ‐C30 and SKINDEX‐29 measurement of health‐related quality of life in patients with mycosis fungoides and Sézary syndrome: Real‐world data in Spanish patients (MICADOS Study)

  2022cites this paper
• Elevated levels of cytochrome p450scc and 3β-hydroxysteroid dehydrogenase expression in skin of acne vulgaris patients

  2022cites this paper
• Assessment of serum androgen levels in women with acne vulgaris in Southeastern Nigeria: a cross-sectional study

  2022cites this paper
• The potential role of insulin‐like growth factor 1 in acne vulgaris and its correlation with the clinical response before and after treatment with metformin

  2022cites this paper
• Acne Vulgaris and Metabolic Syndrome: A Possible Association

  2022cites this paper
• Nutrition and acne, hidradenitis suppurativa, and Isotretinoin.

  2022cites this paper
• Lebensqualität von Patienten mit Mycosis fungoides und Sézary-Syndrom

  2022cites this paper
• Insulin resistance and idiopathic hirsutism: A systematic review, meta‐analysis, and meta‐regression

  2022cites this paper
• Relation of polycystic ovarian syndrome phenotypes with cutaneous and biochemical hyperandrogenism: a case–control study

  2022cites this paper
• How we treat mycosis fungoides and Sézary syndrome.

  2021cites this paper
• PGPM_A_341723 1679..1687

  2021influential citation
• Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature

  2021influential citation
• Red Seaweed-Derived Compounds as a Potential New Approach for Acne Vulgaris Care

  2021cites this paper
• Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy.

  2021cites this paper
• Prevalence of acne vulgaris and its clinico‐epidemiological pattern in adult patients: Results of a prospective, observational study

  2021cites this paper
• Does isotretinoin have an effect on glucose metabolism, insulin growth factor-1 and insulin-like growth factor-3 binding protein?

  2021cites this paper
• Bisphenol A-induced DNA damages promote to lymphoma progression in human lymphoblastoid cells through aberrant CTNNB1 signaling pathway

  2021cites this paper
• ACNE VULGARIS, RECENT UPDATES ON PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT-A SYSTEMIC REVIEW STUDY

  2021cites this paper
• Isotretinoin Induced Hyperlipidemia and Impact of Leptin Gene rs 7799039 Polymorphism in Safety of Acne Patients

  2021cites this paper
• Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial

  2021cites this paper
• Health‐related quality of life in cutaneous T‐cell lymphoma: A cross‐sectional survey study

  2021influential citation
• Evaluation of serum insulin‐like growth factor‐1, insulin, glucose levels in patients with adolescent and post‐adolescent acne

  2021cites this paper
• Dual role of Cutibacterium acnes in acne vulgaris pathophysiology

  2021cites this paper
• The impact of gender, age, race/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas

  2021cites this paper
• Quality of Life Impact of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma

  2021cites this paper
• Innate and Adaptive Immunity in Acne Vulgaris

  2021cites this paper
• Inflammatory Disorders: Psoriasis, Lichen Planus, Pityriasis Rosea, and Sarcoidosis

  2021cites this paper
• Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma.

  2021cites this paper
• The role of insulin-like growth factor-1 in the pathogenesis of cancer and inflammatory skin diseases

  2020cites this paper
• A Molecular Perspective on the Potential Benefits of Metformin for the Treatment of Inflammatory Skin Disorders

  2020cites this paper
• The relationship among androgens, insulin resistance and ghrelin polymorphisms in post-adolescent male patients with severe acne vulgaris

  2020cites this paper
• The clinical and humanistic burden of cutaneous T-cell lymphomas and response to conventional and novel therapies: results of a systematic review

  2020cites this paper
• FASCE, the benefit of spironolactone for treating acne in adult females: study protocol for a randomized double-blind trial

  2020cites this paper
• Review of Clinical Factors That Cause Acne Vulgaris

  2020cites this paper
• A Correlation between Serum Level of Alkaline Phosphatase and Acne Severity in Children and Adolescents: A Retrospective Cross-Sectional Study

  2020cites this paper
• Endocrinology and immunology of acne: Two sides of the same coin

  2020cites this paper
• Acne as an altered dermato‐endocrine response problem

  2020cites this paper
• Serum Levels of Insulin Like Growth Factor-1(IGF-1) in Patients with Seborrheic Dermatitis

  2020cites this paper
• Effects of Isotretinoin Treatmenton Levels of Hormones Involvedin the Etiopathogenesis of Acne

  2020cites this paper
• FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial

  2020cites this paper
• Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma.

  2020cites this paper
• The Role of Diet in Acne Vulgaris and Its Complications: Clinical Study in Sulaimani Teaching Center of Dermatology

  2020cites this paper
• Clinical severity measures and quality‐of‐life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology‐specific instruments

  2020cites this paper
• Psychiatric comorbidity, depression, and anxiety levels and quality of life of the patients with mycosis fungoides

  2020cites this paper
• The Skin, Selected Dermatologic Conditions, and Medical Nutrition Therapy

  2020cites this paper
• Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study.

  2020cites this paper
• Do acne treatments affect insulin‐like growth factor‐1 serum levels? A clinical and laboratory study on patients with acne vulgaris

  2020cites this paper
• Current measures are not sufficient: an interview‐based qualitative assessment of quality of life in cutaneous T‐cell lymphoma *

  2020cites this paper
• The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T‐cell lymphoma

  2020influential citation
• The Insulin-like Growth Factor-1 (G>A) and 5,10-methylenetetrahydrofolate Reductase (C677T) Gene Variants and the Serum Levels of Insulin-like Growth Factor-1, Insulin, and Homeostasis Model Assessment in Patients with Acne Vulgaris

  2020cites this paper
• Role of insulin-like growth factor 1 in pathogenesis of acne vulgaris: relation to acne severity and body mass index

  2020cites this paper
• Neuroendocrinology and neurobiology of sebaceous glands

  2020cites this paper
• Evaluation of serum FoxO1, mTORC1, IGF‐1, IGFBP‐3 levels, and metabolic syndrome components in patients with acne vulgaris: A prospective case‐control study

  2020cites this paper
• Skindex-29 scores indicate poor quality of life in early stage mycosis fungoides.

  2020cites this paper
• Menopausal Acne – Challenges And Solutions

  2019cites this paper
• Cutaneous T Cell Lymphoma: Ready To Enter The World of Allogeneic Transplant?

  2019cites this paper
• Role of Insulin Resistance in Acne Vulgaris : A Hospital Based Observational Study

  2019cites this paper
• Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study

  2019cites this paper
• Cutaneous manifestations in obese patients and non-obese controls in a tertiary care centre: a case-control study

  2019cites this paper
• Itching for the right treatment

  2019cites this paper
• HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome.

  2019cites this paper
• New and emerging drugs for the treatment of acne vulgaris in adolescents

  2019cites this paper
• Health‐related quality of life and economic implications of cutaneous T‐cell lymphoma

  2019cites this paper
• Skin changes in the obese patient.

  2019cites this paper
• Comparison of serum dehydroepiandrosterone sulfate, testosterone, and dihydrotestosterone levels in males with various degrees of acne vulgaris severity

  2019cites this paper
• Autism Spectrum Disorders and Perinatal Complications—Is Oxidative Stress the Connection?

  2019cites this paper
• Health-related Quality of Life in Cutaneous Lymphomas: Past, Present and Future.

  2019influential citation
• Antimicrobial peptides, novel solution for the treatment of precancerous disease acne - A review

  2019cites this paper
• CAG polymorphism in the androgen receptor gene in women may be associated with nodulocystic acne

  2019cites this paper
• Der Einfluss westlicher Ernährung

  2019cites this paper
• ACNE PROTECTION: MEASURES AND MISERIES

  2019cites this paper
• Survivin and insulin-like growth factor-I: potential role in the pathogenesis of acne and post-acne scar

  2019cites this paper
• Adult-onset acne: prevalence, impact, and management challenges

  2018cites this paper
• Designing Skin Cancer Prevention Messages: Should We Emphasize Gains or Losses? Message Framing, Risk Type, and Prior Experience

  2018cites this paper
• Effect and Tolerability of the Combined Plant Extract (PAC) in Treatment of Acne Vulgaris

  2018cites this paper
• Acne and nutrition: hypotheses, myths and facts

  2018cites this paper
• Diseases of Civilization - Cancer, Diabetes, Obesity and Acne - the Implication of Milk, IGF-1 and mTORC1.

  2018cites this paper